B
BeiBangAn
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C | 23 | 7.0 | 4.4 | 9.8 | 29 Oct 2025 |
| Tirzepatide | D | 15 | 6.9 | 4.0 | 10.0 | 5 Dec 2025 |
| AA Water | C | 2 | 6.8 | 5.8 | 7.9 | 23 May 2026 |
| AICAR | X | 1 | 7.6 | 7.6 | 7.6 | 25 Apr 2025 |
| Anastrozole (Arimidex) Raw | C | 3 | 7.6 | 5.4 | 9.8 | 23 May 2026 |
| BPC-157 Arg Oral | C | 3 | 6.4 | 3.5 | 9.2 | 23 May 2026 |
| Chonluten | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 7.0 | 7.0 | 7.0 | 24 Apr 2025 |
| Clomid | C | 3 | 7.3 | 5.4 | 8.5 | 23 May 2026 |
| Crystagen | C | 3 | 5.9 | 4.8 | 7.0 | 17 May 2026 |
| DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | C | 3 | 7.6 | 6.5 | 9.2 | 23 May 2026 |
| DNP | C | 2 | 7.8 | 7.8 | 7.9 | 24 May 2026 |
| DSIP | C | 2 | 5.7 | 5.5 | 5.9 | 21 May 2026 |
| Epithalon | X | 1 | 7.0 | 7.0 | 7.0 | 13 Jun 2025 |
| Finasteride | C | 2 | 6.3 | 4.7 | 8.0 | 21 May 2026 |
| FOXO4 | X | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 |
| Glutathione | X | 1 | 9.4 | 9.4 | 9.4 | 28 Mar 2025 |
| HGH 191AA (Somatropin) | C | 3 | 8.2 | 7.4 | 8.7 | 25 May 2026 |
| IGF-1 LR3 | C | 2 | 6.2 | 5.1 | 7.2 | 26 Jan 2026 |
| Ivermectin | X | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 |
| Letrozole | C | 3 | 8.8 | 8.5 | 9.2 | 25 May 2026 |
| Livagen | C | 3 | 6.8 | 6.0 | 7.3 | 24 May 2026 |
| Methylamine (base) CAS 74-89-5 | C | 3 | 6.4 | 5.0 | 7.8 | 24 May 2026 |
| Minoxidil Oral | C | 2 | 6.8 | 6.2 | 7.3 | 24 May 2026 |
| MOTS-C | C | 2 | 5.2 | 5.2 | 5.3 | 17 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | C | 3 | 6.9 | 3.1 | 9.9 | 20 May 2026 |
| NAD+ | X | 1 | 8.8 | 8.8 | 8.8 | 6 May 2025 |
| Nitroethane CAS 79-24-3 | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 |
| Ostarine (MK-2866) | X | 1 | 6.4 | 6.4 | 6.4 | 9 Jun 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X | 1 | 4.1 | 4.1 | 4.1 | 28 Mar 2025 |
| Retatrutide 30mg Pen Kit | C | 3 | 6.0 | 5.4 | 6.4 | 21 May 2026 |
| RIPEX 225 (TRA/Mast P/Test P) | X | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 |
| Selank 10mg + Semax 10mg Blend | C | 2 | 7.5 | 5.9 | 9.1 | 26 Jan 2026 |
| Semax | C | 2 | 8.6 | 8.3 | 8.8 | 26 Jan 2026 |
| SLU-PP-332 | C | 3 | 8.2 | 6.3 | 10.0 | 21 May 2026 |
| SNAP-8 | C | 2 | 8.1 | 6.7 | 9.5 | 20 May 2026 |
| SR9009 | C | 3 | 8.0 | 6.5 | 9.1 | 21 May 2026 |
| Superdrol | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 |
| T3 (Liothyronine) | C | 2 | 6.2 | 5.7 | 6.6 | 24 May 2026 |
| Trestolone Acetate (MENT) Raw | C | 3 | 7.2 | 5.1 | 8.5 | 21 May 2026 |
| Vilon | X | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | BPC-157 Arg Oral | 7.5 | 10mg | 10.4mg | +4.2% | 97.76% | Lab F |
| 25 May 2026 | Clomid | 7.5 | 25mg | 28.6mg | +14.2% | 99.91% | Lab F |
| 25 May 2026 | Livagen | 6.6 | 30mg | 33.7mg | +12.4% | 97.39% | Lab G |
| 25 May 2026 | Minoxidil Oral | 5.6 | 25mg | 21.6mg | -13.4% | 97.66% | Lab G |
| 25 May 2026 | SLU-PP-332 | 9.9 | 25mg | 31.2mg | +24.8% | 96.31% | Lab F |
| 24 May 2026 | Anastrozole (Arimidex) Raw | 7.9 | 100g | 85.8g | -14.2% | 95.82% | Lab C |
| 24 May 2026 | Glutathione | 9.6 | 5mg | 5.4mg | +7.5% | 98.78% | Lab C |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 5.2 | 50mg | 60.5mg | +21.1% | 96.01% | Lab F |
| 24 May 2026 | SLU-PP-332 | 10.0 | 100mg | 87.0mg | -13.0% | 98.20% | Lab E |
| 24 May 2026 | Minoxidil Oral | 6.7 | 20mg | 20.4mg | +2.0% | 96.87% | Lab D |
| 24 May 2026 | Trestolone Acetate (MENT) Raw | 5.8 | 5g | 5.0g | -0.2% | 96.98% | Lab D |
| 24 May 2026 | T3 (Liothyronine) | 6.9 | 100mg | 95.3mg | -4.7% | 99.26% | Lab B |
| 24 May 2026 | Trestolone Acetate (MENT) Raw | 8.3 | 5g | 5.9g | +18.4% | 99.46% | Lab C |
| 24 May 2026 | Methylamine (base) CAS 74-89-5 | 6.3 | 5g | 4.5g | -9.8% | 97.98% | Lab F |
| 24 May 2026 | Retatrutide | 7.8 | 30mg | 30.7mg | +2.3% | 99.80% | Lab G |
| 24 May 2026 | Retatrutide | 7.8 | 30mg | 29.4mg | -2.0% | 99.80% | Lab G |
| 24 May 2026 | AICAR | 6.5 | 2mg | 2.4mg | +21.9% | 95.12% | Lab E |
| 24 May 2026 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 7.6 | 10g | 10.1g | +1.1% | 99.95% | Lab B |
| 24 May 2026 | Semax | 6.7 | 50mg | 57.8mg | +15.5% | 96.04% | Lab E |
| 24 May 2026 | T3 (Liothyronine) | 5.2 | 50mg | 61.1mg | +22.3% | 98.15% | Lab E |
| 23 May 2026 | Tirzepatide | 6.8 | 30mg | 31.6mg | +5.3% | 94.16% | Lab E |
| 23 May 2026 | Retatrutide | 8.0 | 20mg | 19.5mg | -2.5% | 99.90% | Lab E |
| 23 May 2026 | Retatrutide | 7.8 | 20mg | 17.3mg | -13.5% | 99.90% | Lab E |
| 23 May 2026 | Tirzepatide | 9.8 | 60mg | 60mg | 99.80% | Lab E | |
| 23 May 2026 | Finasteride | 6.6 | 50mg | 45.7mg | -8.7% | 96.13% | Lab E |
| 23 May 2026 | Letrozole | 8.2 | 10mg | 12.0mg | +20.4% | 97.96% | Lab A |
| 23 May 2026 | Ostarine (MK-2866) | 7.5 | 100mg | 105.4mg | +5.4% | 98.70% | Lab B |
| 23 May 2026 | Nitroethane CAS 79-24-3 | 6.6 | 500g | 534.6g | +6.9% | 96.55% | Lab B |
| 21 May 2026 | Retatrutide | 7.8 | 30mg | 30mg | 99.80% | Lab G | |
| 21 May 2026 | Selank 10mg + Semax 10mg Blend | 6.5 | 20mg | 23.7mg | +18.6% | 96.16% | Lab G |
| 21 May 2026 | Clomid | 6.4 | 50mg | 54.2mg | +8.4% | 96.20% | Lab G |
| 21 May 2026 | Methylamine (base) CAS 74-89-5 | 7.6 | 500g | 489.4g | -2.1% | 97.38% | Lab A |
| 21 May 2026 | MOTS-C | 4.4 | 50mg | 52.1mg | +4.2% | 98.84% | Lab F |
| 20 May 2026 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 8.4 | 1g | 0.9g | -8.7% | 95.21% | Lab F |
| 20 May 2026 | Ivermectin | 7.1 | 20mg | 24.9mg | +24.5% | 96.76% | Lab C |
| 19 May 2026 | DNP | 8.2 | 50mg | 43.9mg | -12.2% | 95.14% | Lab B |
| 19 May 2026 | MOTS-C | 4.1 | 5mg | 5.4mg | +8.6% | 95.26% | Lab F |
| 19 May 2026 | NAD+ | 8.6 | 5mg | 5.0mg | -0.9% | 96.40% | Lab G |
| 17 May 2026 | Anastrozole (Arimidex) Raw | 7.5 | 500g | 551.3g | +10.3% | 95.05% | Lab G |
| 17 May 2026 | Livagen | 7.5 | 30mg | 32.6mg | +8.8% | 95.75% | Lab A |
| 17 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.5 | 200mg/ml | 208.9mg/ml | +4.5% | 99.94% | Lab F |
| 29 Jan 2026 | Clomid | 7.2 | 10mg | 10.1mg | +1.5% | 97.55% | Lab B |
| 29 Jan 2026 | DSIP | 6.4 | 5mg | 4.7mg | -6.9% | 98.15% | Lab A |
| 29 Jan 2026 | Epithalon | 7.3 | 5mg | 4.7mg | -6.4% | 97.78% | Lab E |
| 26 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.8 | 10mg | 9.0mg | -10.3% | 97.67% | Lab D |
| 26 Jan 2026 | Crystagen | 4.0 | 15mg | 18.1mg | +20.9% | 98.90% | Lab B |
| 26 Jan 2026 | DNP | 9.0 | 20mg | 24.8mg | +24.1% | 96.73% | Lab C |
| 26 Jan 2026 | Retatrutide 30mg Pen Kit | 6.9 | 30mg | 32.9mg | +9.6% | 95.11% | Lab D |
| 19 Jan 2026 | IGF-1 LR3 | 6.2 | 30mg | 32.6mg | +8.5% | 98.15% | Lab A |
| 19 Jan 2026 | Letrozole | 10.0 | 50mg | 45.3mg | -9.4% | 96.66% | Lab C |
| 19 Jan 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 4.0 | 1g | 1.1g | +9.2% | 97.32% | Lab D |
| 9 Jan 2026 | BPC-157 Arg Oral | 6.1 | 10mg | 10.8mg | +7.6% | 96.72% | Lab D |
| 9 Jan 2026 | HGH 191AA (Somatropin) | 7.9 | 15mg | 15.4mg | +2.5% | 99.30% | Lab G |
| 9 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.8 | 50mg | 50.4mg | +0.7% | 95.62% | Lab B |
| 9 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.8 | 30mg | 26.1mg | -13.1% | 95.64% | Lab C |
| 7 Jan 2026 | HGH 191AA (Somatropin) | 8.0 | 50mg | 59.4mg | +18.7% | 95.32% | Lab D |
| 6 Jan 2026 | Finasteride | 6.3 | 10mg | 9.6mg | -3.9% | 99.06% | Lab G |
| 6 Jan 2026 | Superdrol | 8.5 | 25mg | 22.8mg | -8.9% | 95.98% | Lab G |
| 6 Jan 2026 | Vilon | 7.6 | 2mg | 1.9mg | -2.9% | 97.40% | Lab C |
| 29 Dec 2025 | DSIP | 7.1 | 2mg | 2.4mg | +18.5% | 97.22% | Lab G |
| 29 Dec 2025 | SNAP-8 | 8.2 | 10mg | 9.3mg | -6.6% | 99.46% | Lab G |
| 12 Dec 2025 | Letrozole | 7.5 | 100mg | 104.7mg | +4.7% | 97.22% | Lab D |
| 12 Dec 2025 | Livagen | 5.1 | 10mg | 9.1mg | -9.1% | 98.14% | Lab B |
| 12 Dec 2025 | SR9009 | 9.0 | 10mg | 11.7mg | +16.6% | 98.01% | Lab A |
| 5 Dec 2025 | Anastrozole (Arimidex) Raw | 8.3 | 500g | 475.4g | -4.9% | 96.01% | Lab B |
| 5 Dec 2025 | Crystagen | 7.3 | 20mg | 24.0mg | +19.8% | 97.29% | Lab G |
| 5 Dec 2025 | IGF-1 LR3 | 7.1 | 50mg | 55.9mg | +11.7% | 98.55% | Lab F |
| 5 Dec 2025 | Methylamine (base) CAS 74-89-5 | 7.4 | 100g | 93.3g | -6.7% | 96.41% | Lab F |
| 5 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.2 | 30mg | 26.2mg | -12.7% | 95.87% | Lab F |
| 23 Nov 2025 | AA Water | 7.2 | 10mg | 12.1mg | +21.2% | 98.25% | Lab F |
| 17 Nov 2025 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 7.8 | 10g | 9.9g | -1.3% | 99.79% | Lab F |
| 17 Nov 2025 | FOXO4 | 6.2 | 50mg | 42.5mg | -15.0% | 99.83% | Lab G |
| 14 Nov 2025 | AA Water | 5.0 | 10mg | 12.2mg | +22.2% | 97.69% | Lab C |
| 14 Nov 2025 | SNAP-8 | 7.9 | 50mg | 51.5mg | +2.9% | 95.35% | Lab A |
| 5 Nov 2025 | BPC-157 Arg Oral | 4.0 | 25mg | 23.7mg | -5.1% | 97.21% | Lab F |
| 5 Nov 2025 | Retatrutide 30mg Pen Kit | 7.7 | 20mg | 17.5mg | -12.6% | 95.53% | Lab E |
| 5 Nov 2025 | Trestolone Acetate (MENT) Raw | 8.4 | 5g | 6.2g | +24.2% | 97.95% | Lab C |
| 4 Nov 2025 | Crystagen | 5.1 | 15mg | 15.1mg | +0.9% | 96.75% | Lab G |
| 17 Oct 2025 | HGH 191AA (Somatropin) | 6.3 | 10mg | 8.9mg | -10.6% | 98.85% | Lab A |
| 17 Oct 2025 | SR9009 | 8.5 | 10mg | 10.2mg | +1.5% | 95.19% | Lab D |
| 17 Oct 2025 | SR9009 | 7.9 | 50mg | 51.3mg | +2.6% | 97.24% | Lab D |
| 9 Oct 2025 | Chonluten | 7.5 | 20mg | 19.1mg | -4.3% | 98.28% | Lab F |
| 9 Oct 2025 | SLU-PP-332 | 6.4 | 50mg | 51.8mg | +3.5% | 99.52% | Lab D |
| 3 Oct 2025 | Retatrutide 30mg Pen Kit | 5.5 | 10mg | 11.3mg | +12.8% | 95.86% | Lab D |
| 3 Oct 2025 | Semax | 9.7 | 2mg | 2.5mg | +23.2% | 97.04% | Lab C |